{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:55:09Z","timestamp":1772758509767,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.amjsurg.2018.10.018","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T03:14:23Z","timestamp":1539659663000},"page":"541-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence"],"prefix":"10.1016","volume":"217","author":[{"given":"Benjamin W.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9299-0408","authenticated-orcid":false,"given":"G. Paul","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2018.10.018_bib1","series-title":"NCCN Clinical Practice Guidelines in Oncology \u2013 Hepatobiliary Cancers. Version 3","author":"National Comprehensive Cancer Network","year":"2018"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/bjs.7583","article-title":"Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria","volume":"98","author":"Fan","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jso.21415","article-title":"Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma","volume":"101","author":"Lee","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005756","article-title":"Liver transplantation versus surgical resection for HCC meeting the Milan criteria","volume":"95","author":"Shen","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.20688","article-title":"Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation","volume":"41","author":"Lu","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jvir.2015.04.004","article-title":"Microwave ablation compared to radiofrequency ablation for hepatic lesions","volume":"26","author":"Huo","year":"2015","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.SLA.0000048443.71734.BF","article-title":"Percutaneous local ablative therapy for hepatocellular carcinoma","volume":"237","author":"Lau","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A\u00a0randomized trial comparing radiofrequency ablation and surgical resection for HCC Conforming to the Milan Criteria","volume":"252","author":"Huang","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A\u00a0prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A\u00a0randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"Feng","year":"2012","journal-title":"J\u00a0Hepatic"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/lt.22273","article-title":"Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria","volume":"17","author":"Hsu","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2036.2005.02404.x","article-title":"The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma","volume":"21","author":"Huang","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/bjs.10061","article-title":"Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria","volume":"103","author":"Liu","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00270-016-1426-y","article-title":"Unresectable hepatocellular carcinoma: radioembolization versus chemoembolization","volume":"39","author":"Lobo","year":"2016","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patient with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib17","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib18","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH)","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib19","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.2017.75.3228","article-title":"Radiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients","volume":"36","author":"Rajyaguru","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","article-title":"Epidemiology and risk factors: intrahepatic cholangiocarcinoma","volume":"6","author":"Gupta","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.21037\/jgo.2018.02.04","article-title":"Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004-2015","volume":"9","author":"Kolarich","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/02656736.2017.1327678","article-title":"Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma","volume":"34","author":"Zhang","year":"2018","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000453010","article-title":"Locoregional therapies of cholangiocarcinoma","volume":"32","author":"Sommer","year":"2016","journal-title":"Vis Med"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib27","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","article-title":"Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma","volume":"20","author":"Hyder","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","article-title":"Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis","volume":"24","author":"Mouli","year":"2013","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib29","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1245\/s10434-014-4365-3","article-title":"Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment","volume":"22","author":"Rayar","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jso.23781","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma","volume":"111","author":"Boehm","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sonc.2002.31679","article-title":"Intrahepatic arterial infusion of chemotherapy: pharmacologic principles","volume":"29","author":"Ensminger","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2010.32.5977","article-title":"Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer","volume":"29","author":"Kemeny","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.29824","article-title":"Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone","volume":"122","author":"Konstantinidis","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1245\/s10434-017-6110-1","article-title":"Surgical resection does not improve survival in multifocal intrahepatic cholangiocarcinoma: a comparison of surgical resection with intra-arterial therapies","volume":"25","author":"Wright","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib35","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijrobp.2008.03.018","article-title":"Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma","volume":"72","author":"Shinohara","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib36","article-title":"Global cancer statistics 2018","author":"Bray","year":"2018","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases - a population-based study on incidence, management and survival","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Canc"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib39","series-title":"NCCN Clinical Practice Guidelines in Oncology \u2013 Colon Cancer. Version 3","author":"National Comprehensive Cancer Network","year":"2018"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib40","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/bjs.10159","article-title":"Single-stage resection and microwave ablation for bilobar colorectal liver metastases","volume":"103","author":"Philips","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bjs.10447","article-title":"Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases","volume":"104","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00270-018-1959-3","article-title":"Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases","volume":"41","author":"Meijerink","year":"2018","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12885-018-4716-8","article-title":"Colorectal liver metastases: surgery versus thermal ablation (COLLISION) \u2013 a phase III single-blind prospective randomized controlled trial","volume":"18","author":"Puijk","year":"2018","journal-title":"BMC Canc"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13063-018-2499-5","article-title":"Liver resection surgery versus thermal ablation for colorectal liver metastases (LAVA): study protocol for a randomised controlled trial","volume":"19","author":"Gurusamy","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib45","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase II study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib46","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1002\/cncr.29534","article-title":"Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis","volume":"121","author":"Martin","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1245\/s10434-014-4164-x","article-title":"Is yttrium-90 radioembolization a viable treatment option or unresecstable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients","volume":"22","author":"Saxena","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/1471-2407-14-497","article-title":"FOXFIRE protocol","volume":"14","author":"Dutton","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib49","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX","volume":"34","author":"van Hazel","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib50","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, FOXFIRE-Global)","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM196402132700701","article-title":"Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion","volume":"270","author":"Sullivan","year":"1964","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib52","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdv548","article-title":"Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV","volume":"27","author":"Levi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.critrevonc.2010.08.001","article-title":"Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection","volume":"79","author":"Power","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib55","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","article-title":"Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer","volume":"261","author":"D'Angelica","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jso.24898","article-title":"Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: long term results and curative potential","volume":"117","author":"Pak","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1245\/s10434-016-5418-6","article-title":"Hepatic arterial infusion in combination with modern systemic chemotherapy is associated with improved survival compared with modern systemic chemotherapy in patients with isolated unresectable colorectal liver metastases","volume":"24","author":"Dhir","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jso.24399","article-title":"Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies","volume":"114","author":"Cercek","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1245\/s10434-017-6265-9","article-title":"Effectiveness of hepatic artery infusion (HAI) versus selective internal radiation therapy (Y90) for pretreated isolated unresectable colorectal liver metastases (IU-CRCLM)","volume":"25","author":"Dhir","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib61","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib62","first-page":"834","article-title":"Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases","volume":"71","author":"Groot Koerkamp","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The Epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib64","first-page":"1955","article-title":"Carcinoid and neuroendocrine tumors: building on success","volume":"22","author":"Kunz","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejrad.2018.01.012","article-title":"Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: a systematic review","volume":"100","author":"Jia","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/hpb.12326","article-title":"Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference","volume":"17","author":"Kennedy","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib67","first-page":"1","article-title":"Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer","author":"Bai","year":"2018","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/SLA.0000000000001371","article-title":"Hepatic resection or ablation for isolated breast cancer liver metastasis","volume":"264","author":"Sadot","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib69","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1245\/s10434-013-3436-1","article-title":"Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients","volume":"21","author":"Saxena","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2018.10.018_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/tbj.12050","article-title":"Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases","volume":"19","author":"Ang","year":"2013","journal-title":"Breast J"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961018310985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961018310985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:14:52Z","timestamp":1757700892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961018310985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0002961018310985"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2018.10.018","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2018.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}